Department of Medical Oncology, Sunnybrook Odette Cancer Centre and University of Toronto, ON.
Women's College Research Institute, Women's College Hospital and University of Toronto, Toronto, ON.
Curr Oncol. 2014 Jun;21(3):e418-25. doi: 10.3747/co.21.1563.
We aimed to identify risk factors for mortality after local recurrence in women treated for invasive breast cancer with breast-conserving surgery.
Our prospective cohort study included 267 women who were treated with breast-conserving surgery at Women's College Hospital from 1987 to 1997 and who later developed local recurrence. Clinical information and tumour receptor status were abstracted from medical records and pathology reports. Patients were followed from the date of local recurrence until death or last follow-up. Survival analysis used a Cox proportional hazards model.
Among the 267 women with a local recurrence, 97 (36.3%) died of breast cancer within 10 years (on average 2.6 years after the local recurrence). The actuarial risk of death was 46.1% at 10 years from recurrence. In a multivariable model, predictors of death included short time from diagnosis to recurrence [hazard ratio (hr) for <5 years compared with ≥10 years: 3.40; 95% confidence interval (ci): 1.04 to 11.1; p = 0.04], progesterone receptor positivity (hr: 0.35; 95% ci: 0.23 to 0.54; p < 0.001), lymph node positivity (hr: 2.1; 95% ci: 1.4 to 3.3; p = 0.001), and age at local recurrence (hr for age >45 compared with age ≤45 years: 0.61; 95% ci: 0.38 to 0.95; p = 0.03).
The risk of death after local recurrence varies widely. Risk factors for death after local recurrence include node positivity, progesterone receptor negativity, young age at recurrence, and short time from diagnosis to recurrence.
我们旨在确定接受保乳手术治疗浸润性乳腺癌后局部复发女性的死亡风险因素。
我们的前瞻性队列研究纳入了 1987 年至 1997 年期间在女子学院医院接受保乳手术治疗且随后发生局部复发的 267 例女性患者。临床信息和肿瘤受体状态从病历和病理报告中提取。患者从局部复发之日起随访至死亡或末次随访。生存分析采用 Cox 比例风险模型。
在 267 例局部复发的女性中,97 例(36.3%)在 10 年内死于乳腺癌(平均在局部复发后 2.6 年)。复发后 10 年的死亡风险为 46.1%。在多变量模型中,死亡的预测因素包括从诊断到复发的时间较短[与≥10 年相比,<5 年的风险比(HR)为 3.40;95%置信区间(CI):1.04 至 11.1;p=0.04]、孕激素受体阳性(HR:0.35;95%CI:0.23 至 0.54;p<0.001)、淋巴结阳性(HR:2.1;95%CI:1.4 至 3.3;p=0.001)和局部复发时的年龄(与年龄≤45 岁相比,年龄>45 岁的 HR 为 0.61;95%CI:0.38 至 0.95;p=0.03)。
局部复发后死亡的风险差异很大。局部复发后死亡的风险因素包括淋巴结阳性、孕激素受体阴性、复发时年龄较小和从诊断到复发的时间较短。